LP220646-6
Paritaprevir
Active
Description
Paritaprevir (previously known as ABT-450) is an inhibitor of the NS3-4A serine protease, and has demonstrated in vitro antiviral activity against several hepatitis C virus (HCV) genotypes, including 1a, 1b, 2a, 3a, 4a, and 6a. Co-administation with ritonavir, ombitasvir and dasabuvir, referred to as the 3D regimen, has proven effective for the treatment of HCV genotype 1 infection. PMID: 26710243 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Paritaprevir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-07-18
- Construct for LOINC Short Name
- Paritaprevir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP220646-6
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 帕利瑞韦 Synonyms: Paritaprevir; |
| es-ES | Spanish (Spain) | Paritaprevir |
| it-IT | Italian (Italy) | Paritaprevir |
| nl-NL | Dutch (Netherlands) | paritaprevir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright